Growing Together: Women in Opioid Treatment and Their Infants
Substance-Related Disorders
About this trial
This is an interventional treatment trial for Substance-Related Disorders focused on measuring maternal opioid use, substance use, parent-child relationship, parenting, social and emotional development, mental health and well-being, perinatal, postpartum, health disparities
Eligibility Criteria
Inclusion Criteria:
- A patient at BUMC RESPECT clinic with history of opioid use or history of polysubstance use
- 18 years orolder
- Being treated with methadone, naltrexone, or suboxone
- In 3rd trimester of pregnancy
- Deemed by MDs able to give informed consent
- Planning to parent infant after birth
- Willing to participate in RCT
Exclusion Criteria:
- Planning to relinquish custody of neonate
- Residing, or expected to reside post-birth 20+ miles from Boston
- Deemed by MDs unable to give informed consent
Sites / Locations
- Boston Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
BRIGHT
STAR/TAU+
Building Resilience through Intervention: Growing Healthier Together (BRIGHT) weekly home-based intervention from the third trimester of pregnancy through 6 months postpartum. A licensed clinician meets with mother and infant to promote attunement and optimal parent-child interactions. Additionally, the mother receives monthly handouts focused on information about child development and recovery from substance misuse while parenting, along with the standard of care at a high risk maternal-fetal medical clinic
The mother receives monthly handouts focused on information about child development and recovery from substance misuse while parenting, along with the standard of care at a high risk maternal-fetal medical clinic.